Jonathan Sorof
Plus aucun poste en cours
Profil
Jonathan Sorof worked as the Global Head of Pediatric Oncology Regulatory Affairs at AstraZeneca PLC and as the Senior Vice President of Medical and Regulatory Affairs at Global Blood Therapeutics, Inc. He holds a doctorate degree from Perelman School of Medicine.
Anciens postes connus de Jonathan Sorof
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formation de Jonathan Sorof
| Perelman School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
